SAVI SYNDROME: LITERATURE REVIEW AND FAMILY CASE IN RHEUMATOLOGY AND PULMONOLOGY

2021 ◽  
Vol 100 (5) ◽  
pp. 180-187
Author(s):  
S.O. Salugina ◽  
◽  
E.S. Fedorov ◽  
N.S. Lev ◽  
S.O. Zhikrivetskaya ◽  
...  

SAVI syndrome – STING-associated early-onset vasculopathy – a rare monogenic autosomal dominant autoinflammatory disease associated with a mutation in the TMEM173 gene, belongs to type 1 interferonopathies. It is characterized by early onset, fever, skin rashes (vasculopathy), arthritis, interstitial lung disease (ILD), increased levels of acute phase markers, and the presence of autoantibodies (antinuclear factor, rheumatoid factor and other antibodies). The main treatment is glucocorticoids, JAK inhibitors. This publication provides an overview of the literature on this rare disease, as well as a few family observations. We present our own clinical cases: 2 children from twins and a father from the same family suffering from SAVI syndrome, the therapy of these patients, a complex diagnostic path, including genetic diagnostics, starting with a pulmonologist, a geneticist and ending with a rheumatologist. When analyzing the presented family case, it is obvious that patients with SAVI syndrome can encounter in the practice of a rheumatologist and a pulmonologist. Children with early onset with systemic manifestations (fever, skin rashes, lymphadenopathy, hepatolienal syndrome), arthritis in combination with ILD, increased ESR, C-reactive protein, and the presence of autoantibodies require special attention. It is extremely important to collect a family history to identify similar cases in relatives and to perform genetic testing in a timely manner.

2021 ◽  
Vol 84 (1) ◽  
pp. 2337-2343
Author(s):  
Sabry Abdel Rahman Tolba ◽  
Hadeel Mohammad Abd-Elrahman ◽  
Randa Hussiny Mohamed ◽  
Khaled Abdulhafid Moftah Hendi

2020 ◽  
Vol 13 (1) ◽  
pp. e227379
Author(s):  
Gustavo Ferrer ◽  
Alwiya Omar Saleh ◽  
Henry D Tazelaar ◽  
Andrea V Arrossi

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with multiple systemic manifestations. Pulmonary involvement has been reported in the form of interstitial fibrosis, emphysema, pulmonary hypertension and thoracic neoplasm. We report a case of desquamative interstitial pneumonia in a non-smoker with NF1.


Diabetes Care ◽  
2008 ◽  
Vol 31 (5) ◽  
pp. 974-976 ◽  
Author(s):  
M. L. Marcovecchio ◽  
C. Giannini ◽  
B. Widmer ◽  
R. N. Dalton ◽  
S. Martinotti ◽  
...  

2012 ◽  
Vol 38 (1) ◽  
pp. 174-179 ◽  
Author(s):  
Jonas Vejvad Nørskov Laursen ◽  
Stine Skovbo Hoffmann ◽  
Anders Green ◽  
Mads Nybo ◽  
Anne Katrin Sjølie ◽  
...  

2012 ◽  
Vol 57 (No. 10) ◽  
pp. 529-535 ◽  
Author(s):  
K. Tamura ◽  
N. Nagashima ◽  
H. Oda ◽  
M. Kunimi ◽  
T. Itoi ◽  
...  

  The levels of rheumatoid factor (RF), antinuclear antibody (ANA), and composition of peripheral lymphocyte subsets in 515 dogs were examined. Of these sample cases, 33 cases were diagnosed as immune-mediated fever that presented with high C-reactive protein (CRP), 31 cases were diagnosed with Hansen’s Type 1 disc herniation and the remaining 415 cases were clinically healthy dogs, and served as controls. In the cases diagnosed with immune-mediated fever, 84% of the dogs tested positive to either RF or ANA (RF positive 60.6%; ANA positive 24.2%). By contrast, 16.2% of the healthy dogs were positive for either RF or ANA (RF positive 14.9%; ANA 1.3%). The CD4/CD8 ratio for peripheral lymphocyte was high for all analysed cases diagnosed with immune-mediated fever, and was significantly higher than those of healthy controls. These results indicate that the abnormal levels of lymphocytes may be an effective indicator for immune-mediated disease coupled to immune-mediated fever.  


2001 ◽  
Vol 47 (6) ◽  
pp. 1016-1022 ◽  
Author(s):  
Claudio Chiesa ◽  
Fabrizio Signore ◽  
Marcello Assumma ◽  
Elsa Buffone ◽  
Paola Tramontozzi ◽  
...  

Abstract Background: There is a wide range of reported sensitivities and specificities for C-reactive protein (CRP) and interleukin-6 (IL-6) in the detection of early-onset neonatal infection. This prompted us to assess reference intervals for CRP and IL-6 during the 48-h period immediately after birth and to identify maternal and perinatal factors that may affect them. Methods: CRP and IL-6 values were prospectively obtained for 148 healthy babies (113 term, 35 near-term) at birth and at 24 and 48 h of life, and from their mothers at delivery. Results: Upper reference limits for CRP at each neonatal age were established. At birth, CRP was significantly lower than at 24 and 48 h of life. Rupture of membranes ≥18 h, perinatal distress, and gestational hypertension significantly affected the neonatal CRP dynamics, but at specific ages. There was no correlation between CRP concentrations in mothers and their offspring at birth. The IL-6 values observed in the delivering mothers and in their babies at all three neonatal ages were negatively associated with gestational age. In the immediate postnatal period, IL-6 dynamics for term babies were significantly different from those for near-term babies. Maternal IL-6 concentrations correlated with babies’ IL-6 concentrations only for term deliveries. Apgar score had a significant effect on babies’ IL-6 values at birth. Conclusions: The patterns of CRP and IL-6 responses in the healthy neonate should be taken into account to optimize their use in the diagnosis of early-onset neonatal sepsis.


Sign in / Sign up

Export Citation Format

Share Document